Skip to content

Grants to Oregon Health & Science University

Amount Purpose Term Source
$538,878 To evaluate the impact of providing incentives for contraceptive use. 2018 - 2021 LJAF
$921,833 To fund the development of a centralized repository of documented medical practices that have been contradicted by rigorous, high-quality evaluations. 2017 - 2020 LJAF
$3,145,641 To support the Donor Management Research Initiative in its efforts to maximize the quality and quantity of life-saving organs, and to build a national, web-based donor management data registry. 2016 - 2022 LJAF
$384,252 To work with several state partners to evaluate and design different payment-related incentives that state health care purchasers can utilize to help reduce the use of low-value healthcare services. 2021 - 2022 LJAF
$50,729 To support a review of evidence for existing methadone regulatory schemes and to identify research needs to inform future methadone policy 2020 - 2021 LJAF
$597,880 To fund the State Medicaid Alternative Reimbursement and Purchasing Test for High-Cost Drugs Initiative. 2017 - 2018 LJAF
$2,172,049 To fund the State Medicaid Alternative Reimbursement and Purchasing Test for High Cost Drugs (SMART-D) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions, technical assistance, and education 2019 - 2022 LJAF
$1,582,837 To support efforts to improve the Medicaid drug purchasing process through research and design of value-based payment models. 2016 - 2017 LJAF
$1,735,814 To support the evaluation of state Medicaid policies on contraceptive access. 2020 - 2024 LJAF
$1,248,251 To evaluate a statewide policy in Oregon allowing pharmacists to prescribe hormonal contraception to patients without a physician visit. 2018 - 2022 LJAF


Arnold Ventures funds projects to understand problems and identify policy solutions.

Map of the U.S. made of Arnold Ventures icons